The chemistry and physiology — Mn-SOD and cartilage synthesis
Manganese is a transition metal with chemistry similar to iron but distinct biological functions. Per standard biochemistry references, manganese exists in canine tissue primarily as Mn(II) and Mn(III) oxidation states and serves as a cofactor for several enzyme classes with no direct substitute. The most clinically relevant manganese-dependent enzyme is manganese-superoxide-dismutase (Mn-SOD, gene SOD2), the mitochondrial-matrix isoform of the superoxide dismutase family. Per Bhagavan 2006 (Free Radic Res) and the broader oxidative-stress literature, Mn-SOD catalyzes the dismutation of superoxide radical (O2−) to hydrogen peroxide (H2O2) inside mitochondria, where the bulk of cellular reactive oxygen species are generated during oxidative phosphorylation. Without functional Mn-SOD, mitochondrial oxidative damage accumulates rapidly.
The second major manganese-dependent enzyme class is the glycosyltransferases involved in proteoglycan synthesis. Per Hurley 1981 (Physiol Rev) classical manganese deficiency review, manganese-deficient animals develop skeletal abnormalities, impaired cartilage formation, and altered glycosaminoglycan composition because key cartilage glycosyltransferases require manganese as a cofactor. The clinical relevance to canine orthopedic development is meaningful but rarely seen in dogs eating AAFCO-compliant diets — manganese deficiency requires substantial dietary inadequacy that does not occur with normal commercial feeding. Per AAHA 2022 Pain Management Guidelines context, manganese is not positioned as a joint-support supplement in the way that glucosamine, chondroitin, and marine omega-3 are; it is positioned as a baseline cofactor required at sufficient amounts for normal cartilage maintenance.
AAFCO 2024 dog food nutrient profiles — minimum 5 mg/kg DM
Per AAFCO 2024 Official Publication dog food nutrient profiles, manganese is specified with the following minimum amounts: adult maintenance 5 mg/kg dry matter (DM), growth and reproduction 7.2 mg/kg DM. No maximum (upper limit) is specified in current AAFCO profiles, reflecting that canine manganese toxicity from dietary sources is rare under normal feeding circumstances. Per NRC 2006 (Nutrient Requirements of Dogs and Cats), the upper safe limit is undefined for dogs but available data from other species suggest a substantial safety margin between requirement and toxicity.
The practical implication is that AAFCO-compliant commercial dog foods uniformly meet the manganese requirement by default. Typical commercial diet manganese content is 10–30 mg/kg dry matter, comfortably above the 5–7.2 mg/kg minimum and far below any concern threshold. Owners do not need to track manganese separately or supplement with manganese unless a veterinarian identifies a specific clinical indication. See our zinc supplements explainer, iron supplements explainer, and copper supplements explainer for the other AAFCO-required trace minerals with similar but narrower-window framing.
Common manganese ingredients in pet food labels
Per AAFCO 2024 Official Publication ingredient definitions and 21 CFR 184 GRAS list, the most common manganese ingredients in commercial dog food labels are manganese sulfate, manganese oxide, manganese proteinate, and manganese amino-acid chelate (also called manganese amino-acid complex). The chelated forms — manganese proteinate, manganese amino-acid chelate, manganese polysaccharide complex — bind the mineral to small organic molecules (amino acids, short peptides, sugar derivatives), protecting it from antagonistic gut interactions and presenting it ready for intestinal absorption.
Per Wedekind 1991 (J Anim Sci) and Lowe 1994 (J Anim Sci) controlled animal studies, chelated manganese typically has 10–25% higher absorption than manganese oxide. The mechanism, per Sandstrom 1985 (Acta Pharmacol Toxicol) phytate-mineral interaction work and broader mineral-bioavailability literature, is that phytate (the storage phosphorus form in grains and legumes) and dietary fiber bind oxide and sulfate mineral forms in the gut lumen, while chelated forms resist this binding. For manganese specifically, the practical clinical relevance of the bioavailability difference is modest because of the generous AAFCO safety margin between requirement and toxicity. Chelation matters more for minerals with narrower windows (iron, zinc, copper) where small absorption differences accumulate into meaningful status differences.
Deficiency and excess — both clinically rare in dogs
Per Hurley 1981 and the broader manganese-deficiency literature, manganese deficiency in animal models produces skeletal abnormalities (chondrodystrophy, ataxia in some species), impaired growth, and altered cartilage glycosaminoglycan composition. In dogs eating AAFCO-compliant diets, clinical manganese deficiency essentially does not occur. Reports of clinical manganese deficiency in dogs are exceedingly rare and require substantial dietary inadequacy (e.g., long-term home-prepared diets without mineral premix supplementation). Per Pluta 2025 (Front Vet Sci) home-prepared diet nutritional analyses, manganese (alongside zinc, iodine, and copper) is among the most commonly under-formulated trace minerals in unsupplemented home-cooked diets — reinforcing that the AAFCO requirement reflects a real biological need, not an artifact.
Manganese excess from dietary sources is similarly rare in dogs. Inhalation manganese toxicity is well-described in human occupational medicine (manganese miners, welding-fume exposure) producing a Parkinson-like neurodegenerative syndrome called manganism, but this exposure route is irrelevant to dogs eating commercial pet food. Oral manganese toxicity from typical AAFCO-compliant diet ranges is not reported in dogs. The substantial safety margin underlying the AAFCO 2024 framework reflects this reality.
How KibbleIQ scores manganese
The KibbleIQ Dry Kibble Rubric awards mineral-form bioavailability credit when chelated manganese forms (manganese proteinate, manganese amino-acid chelate, manganese amino-acid complex, manganese polysaccharide complex) are declared on the ingredient list, versus oxide or sulfate forms. The rubric does not penalize manganese oxide or manganese sulfate presence — both meet AAFCO 2024 requirements when included at appropriate levels in a complete formulation. The chelation credit reflects the Wedekind 1991 bioavailability evidence in animal models, applied as an additive quality signal rather than a deficiency-correction need.
Manganese itself is not a rubric-distinctive ingredient — all AAFCO-compliant complete dog foods meet the requirement and most exceed it by 2–6×. The clinical-decision framework for owners is that manganese is not a tracked-supplement nutrient in the way that EPA + DHA, glucosamine, or taurine are. Manganese is a baseline cofactor that AAFCO-compliant formulations cover by default. See our zinc supplements explainer, iron supplements explainer, and copper supplements explainer for the trace-mineral family context. To check whether your dog’s food declares chelated mineral forms, paste the ingredient list into the KibbleIQ analyzer.